Advanced Cell Technology, Inc. will participate at the European Stem Cells & Regenerative Medicine Congress 2006, June 5-7, at Jumeirah Carlton Tower, London, United Kingdom. Michael D. West, Ph.D., Chairman, President and Chief Scientific Officer, is scheduled to take part in a panel discussion titled Realizing Therapeutic Potential, on Wednesday, June 7th. Dr. West will discuss strategies for the accelerated development of therapeutics from human embryonic stem cells, introduce the Company's ACTCellerate technology platform, and show data on the first new differentiated cells derived using the technology, designated ACTC60.
Genetic Engineering News
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
Biom’up’s Laparoscopic Applicator Earns New Marketing Approval
The device quickly delivers Hemoblast powder to bleeding areas in minimally-invasive surgeries.
Lawmakers Want Probe of BMS/Celgene Deal
The cancer drugs the company will acquire as part of the deal include Celgene’s blockbuster drug Revlimid.
FDAnews Device Daily Bulletin
ADVANCED CELL TECHNOLOGY UNVEILS ACTCELLERATE TECHNOLOGY PLATFORM
June 8, 2006
